Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02919813 · ClinicalTrials.gov registry record · NA

M-gCBT for Women With Provoked Localized Vulvodynia

A NA study of Provoked Localized Vulvodynia, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT02919813 is a NA study of Provoked Localized Vulvodynia that has completed, run by Oregon Health and Science University. The registered enrollment target is 31 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02919813, a NA study of Provoked Localized Vulvodynia, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn more about Mindfulness based Group Cognitive Behavior Therapy (M-gCBT) as a treatment for Provoked Localized Vulvodynia (PLV). M-gCBT is a counseling technique that has been shown to reduce pain and anxiety with other medical conditions, including chronic pain conditions. The investigators wish to see if participation in M-gCBT course will help reduce anxiety, fear, and pain in women with PLV greater than education alone. Both techniques use a group setting including other women with PLV. "Mindfulness-Based Group Cognitive Behavior Therapy for Women with Localized Vulvodynia" is a study designed to learn more about the use of mindfulness based group cognitive behavior therapy for PLV pain and anxiety over education alone. Participants will be randomized to one of two groups: mindfulness based cognitive behavior therapy or group education seminars.

Interventions

  • BEHAVIORAL Mindfulness Based Group Cognitive BehaviorTherapy
  • BEHAVIORAL Educational Seminars

Study Locations (1)

Oregon

  • Oregon Health and Science University - Portland

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2015-12-16
Est. Completion 2017-09-30
Phase NA

What the Registry Record Tells You About NCT02919813

The ClinicalTrials.gov registry entry for NCT02919813 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Provoked Localized Vulvodynia appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Based Group Cognitive BehaviorTherapy is the first listed.

NCT02919813 reports 1 study location spanning 1 distinct geographic area - top geographies include Oregon.

Frequently Asked Questions

What is clinical trial NCT02919813 about?

NCT02919813 is a clinical study titled "M-gCBT for Women With Provoked Localized Vulvodynia". The purpose of this study is to learn more about Mindfulness based Group Cognitive Behavior Therapy (M-gCBT) as a treatment for Provoked Localized Vulvodynia (PLV). M-gCBT is a counseling technique that has been shown to reduce pain and anxiety with other medical conditions, including chronic pain c...

What is the current status of trial NCT02919813?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2015-12-16. Estimated completion is 2017-09-30.

What conditions does trial NCT02919813 study?

This clinical trial studies the following conditions: Provoked Localized Vulvodynia.

What interventions are being tested in trial NCT02919813?

The interventions under investigation include: Mindfulness Based Group Cognitive BehaviorTherapy (BEHAVIORAL), Educational Seminars (BEHAVIORAL).

Who is sponsoring clinical trial NCT02919813?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02919813 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.